Literature DB >> 10570292

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.

U Gileadi1, H T Moins-Teisserenc, I Correa, B L Booth, P R Dunbar, A K Sewell, J Trowsdale, R E Phillips, V Cerundolo.   

Abstract

Generation of the HLA-A0201 (A2) influenza Matrix 58-66 epitope contained within the full-length Matrix protein is impaired in cells lacking the proteasome subunits low molecular protein 2 (LMP2) and LMP7. This Ag presentation block can be relieved by transfecting the wild-type LMP7 cDNA into LMP7-deficient cells. A mutated form of LMP7, lacking the two threonines at the catalytic active site, was equally capable of relieving the block in presentation of the influenza Matrix A2 epitope. These observations were extended by analyzing whether modification of the influenza Matrix protein could overcome the block in presentation of the A2 Matrix epitope. Expression of either a rapidly degraded form of the full-length Matrix protein or shorter Matrix fragments led to an efficient presentation of the A2 influenza Matrix epitope by LMP7-negative cells. These findings demonstrate two main points: 1) LMP7 incorporation into the proteasome is of greater importance for the generation of the influenza A2 Matrix epitope than the presence of the LMP7's catalytic site; and 2) the interplay between cytosolic proteases and stability of target proteins is of importance in optimization of Ag presentation. These observations may have relevance to the immunodominance of tumor and viral epitopes and raise the possibility that generation of shorter protein fragments could be a mechanism to ensure optimal Ag presentation by cells expressing low levels of LMP7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570292

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

2.  Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules.

Authors:  Benoît Guillaume; Jacques Chapiro; Vincent Stroobant; Didier Colau; Benoît Van Holle; Grégory Parvizi; Marie-Pierre Bousquet-Dubouch; Ivan Théate; Nicolas Parmentier; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

3.  Three immunoproteasome-associated subunits cooperatively generate a cytotoxic T-lymphocyte epitope of Epstein-Barr virus LMP2A by overcoming specific structures resistant to epitope liberation.

Authors:  Yoshinori Ito; Eisei Kondo; Ayako Demachi-Okamura; Yoshiki Akatsuka; Kunio Tsujimura; Mitsune Tanimoto; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Cross Talk between Radiation and Immunotherapy: The Twain Shall Meet.

Authors:  Swaminathan P Iyer; Clayton R Hunt; Tej K Pandita
Journal:  Radiat Res       Date:  2017-12-20       Impact factor: 2.841

5.  Impaired tumor antigen processing by immunoproteasome-expressing CD40-activated B cells and dendritic cells.

Authors:  Karen S Anderson; Wanyong Zeng; Tetsuro Sasada; Jaewon Choi; Angelika B Riemer; Mei Su; Donna Drakoulakos; Yoon-Joong Kang; Vladimir Brusic; Catherine Wu; Ellis L Reinherz
Journal:  Cancer Immunol Immunother       Date:  2011-03-13       Impact factor: 6.968

6.  Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.

Authors:  Georg Lautscham; Tracey Haigh; Sabine Mayrhofer; Graham Taylor; Debbie Croom-Carter; Alison Leese; Stephan Gadola; Vincenzo Cerundolo; Alan Rickinson; Neil Blake
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

8.  Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.

Authors:  Valeria Tosello; Rita Zamarchi; Anna Merlo; Margherita Gorza; Erich Piovan; Susanna Mandruzzato; Vincenzo Bronte; Xinhui Wang; Soldano Ferrone; Alberto Amadori; Paola Zanovello
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

9.  Differential Recognition of Influenza A Viruses by M158-66 Epitope-Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Martina M Geelhoed-Mieras; Nella J Nieuwkoop; Monique I Spronken; David A M C van de Vijver; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

10.  PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination.

Authors:  Arash Memarnejadian; Courtney E Meilleur; Christopher R Shaler; Khashayarsha Khazaie; Jack R Bennink; Todd D Schell; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-09-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.